Editas Medicine Q1 2024 Adj EPS $(0.76) Misses $(0.66) Estimate
Portfolio Pulse from Benzinga Newsdesk
Editas Medicine (NASDAQ:EDIT) reported a Q1 2024 adjusted EPS loss of $(0.76), missing the consensus estimate of $(0.66) by 15.15%.
May 08, 2024 | 11:04 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Editas Medicine reported a Q1 2024 adjusted EPS loss of $(0.76), missing the consensus estimate of $(0.66) by 15.15%.
Missing earnings estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100